Financial Assistance

RA Patients Should Have Access to Precision Testing

Simple Billing, No Surprises

Certainty — If the out of pocket is estimated to be more than $90, Vectra Customer Service will call you before running the test.

Affordability — Due to insurance coverage and improvements to our financial assistance plan:

  • Over 95% of patients owe $90 or less
  • Up to 70% of patients will owe $0


If you encounter ANY financial hardship associated with your bill, Myriad will work directly with you toward your complete satisfaction.

Here is what you might owe for the Vectra® test:

Medicare — Traditional Medicare fully covers the cost of covered laboratory tests so your cost is typically $0.

Medicaid — Medicaid patients generally have 100% benefits for laboratory tests so your cost is typically $0.

Medicare Advantage, Tricare, or other Government Assistance — Some plans may expect you to cover a portion of the cost. Plans vary.

Employer or other insurance — May expect you to cover a portion of the cost depending on your plan’s copay and/or deductible. You may qualify for CARE assistance (see below) to help with the deductible or copay.

Uninsured — If you make less than $100,400 (based on a family of 4) per year you might be eligible for financial assistance through our CARE Program. If you are uninsured and do not qualify for financial assistance, please contact us at the number below.

If you have any questions about
billing or affordability please call us

1-877-743-8639
$0

Medicare and Medicaid patients have no out of pocket patient responsibility.*


Ways Crescendo can help:

  • CARE financial assistance plan reduction – income levels under $100,400 based on a family of 4†
  • We offer payment plans as low as $15 per month

Financial Assistance

Vectra Care
Financial Assistance

Financial concerns shouldn’t keep you from receiving regular Vectra tests. Download the apply online or download the CARE form and see if you qualify for financial assistance.


Vectra CARE Financial Assistance Income Guidelines

Patients who are at or below 4X the federal poverty limit will qualify

INCOME (example based on a household of four†) Patient Responsibility
0-2X federal poverty limit: less than $50,200 $0
2-3X federal poverty limit: $50,201 – $75,300 $45
3-4X federal poverty limit: $75,301 – $100,400 $90

The Process

STEP 1 – Order
Your Doctor Orders
the Vectra Test

STEP 2 – Get your blood drawn
Either at your doctor’s office, a LABCORP lab or other facility. If the out of pocket is estimated to be more than $90, Vectra Customer Service will call you before running the test.

STEP 3 – Apply for CARE if needed
If you have Medicare skip this step, your cost is $0. Your doctor’s office might have CARE forms or you can download here. If you have any questions about what the test will cost you, please call us at 1-877-RHEUMDX (1-877-743-8639)

STEP 4 – Receive your results
7-10 days after your blood is drawn, you can access your results at my.vectrada.com. Your doctor will also receive your results and will discuss the findings and next steps with you.

STEP 5 – Receive EOB
Your health insurance company will process our claim and then send you an EOB (Explanation of Benefits) within 30-45 days. The EOB is not a bill, but a detailed explanation of the amount your insurance has covered for the Vectra test.

STEP 6 – Your bill
Once your claim is complete, we will send you a statement of what you owe. which can be paid by phone or via mail. Insurance processing takes time and it will likely be several months before you receive this bill from us. We will keep you in the loop along the way. Please call us if you have any questions. 1-877-RHEUMDX (1-877-743-8639)


*Medicare Advantage plans may require a copay.
†Financial Criteria above are based on the January 2017 U.S. Dept. of Health & Human Services Poverty Guidelines, which are subject to change. Myriad reserves the right to terminate or modify its CARE Financial Assistance Program at any time.

Vectra is validated for use in adults diagnosed with RA. Test results are intended to aid in the assessment of disease activity in RA patients when used in conjunction with standard clinical assessment. This test is not intended or validated to diagnose RA.©2018 Crescendo Bioscience, Inc. All rights reserved. Vectra, Crescendo Bioscience, and the associated logos are trademarks or registered trademarks of Crescendo Bioscience, Inc in the United States and other jurisdictions.